EP YAYING Marks Three Years in the U.S., Weaving Cultural Connection Through Eastern Elegance

This month, EP YAYING, the acclaimed Chinese high-end fashion house, celebrates the third anniversary of its boutique at the American Dream Mall in New Jersey. Since its debut in December 2022, the brand has captivated the international fashion scene by masterfully uniting Eastern aesthetics with contemporary design, delivering collections that are as elegant as they […]

New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial of Tinlarebant in Adolescents with Stargardt Disease

(NASDAQ:BLTE), Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in a global Phase 3 trial for Stargardt disease, achieving a statistically significant p-value of 0.0033 Tinlarebant met the primary efficacy endpoint, demonstrating clinical benefit by significantly reducing the lesion growth rate by 36% compared to placebo, as measured by retinal imaging Tinlarebant was

INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former The AZEK Company Investors Who Received James Hardie PLC (NYSE: JHX) Shares in Connection with James Hardie’s Acquisition of AZEK in July 2025 to Contact the Firm

(NYSE:JHX), SAN FRANCISCO, Dec. 01, 2025 (GLOBE NEWSWIRE) — Girard Sharp LLP, a national investment and securities class action firm, is investigating potential securities claims on behalf of former investors of The AZEK Company (“AZEK”) who received shares of James Hardie plc (“James Hardie” or the “Company”) in connection with James Hardie's acquisition of AZEK

DeepHealth Launches Breast Suite, Elevating Breast Cancer Detection, Risk Stratification and Workflow

(NasdaqGM:RDNT), Breast Suite is an industry-leading, comprehensive, and modular AI-powered suite of applications supporting more than 10 million mammograms annually delivering increased breast cancer detection rates,1 risk stratification tools, and viewing and reporting workflow acceleration CHICAGO, Dec. 01, 2025 (GLOBE NEWSWIRE) — DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary

Titan Mining Announces Strong Kilbourne Graphite Project Economics and Expanded U.S EXIM Support to Accelerate U.S. Graphite Independence

(TSX:TI),(NYSE MKT:TII), Poised to be able to Supply Up to 50% of U.S. Natural Graphite Demand with Federal Backing Under EXIM's “Make More in America” Initiative After-Tax NPV(7%) of $513 million, 37% IRR, and 2.7-Year Payback GOUVERNEUR, N.Y., Dec. 01, 2025 (GLOBE NEWSWIRE) — Titan Mining Corporation (TSX:TI, NYSE-A:TII), (“Titan” or the “Company”) an existing

Juniper Biosciences Raises Oversubscribed and Upsized $40 Million Seed Financing to Fund Development of Its Innovative Pipeline

BRIDGEWATER, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) — Juniper Biosciences LLC today announced the closing of an oversubscribed and upsized $40 million seed financing through its parent company, Juniper Radiopharma LLC, co-led by NovaCapital, several high-net-worth individuals, and members of the Club Degli Investitori. “We are thrilled to have the support of a diverse investor

MADD Canada and PEI Liquor Deliver Impactful Sober Driving Messages to PEI Youth

CHARLOTTETOWN, Prince Edward Island, Dec. 01, 2025 (GLOBE NEWSWIRE) — MADD Canada is showcasing its 2025-2026 School Program in collaboration with Provincial Sponsor Prince Edward Island Liquor Control Commission (PEI Liquor) to empower youth to make sober driving choices. Today, students in Grade 9 will attend a special screening of MADD Canada's School Program at

Userful Wins TITAN Platinum Business Award for SaaS Excellence, Underscoring Its Leadership in Critical Operational Infrastructure

Recognition in Information Technology–SaaS Category Honors Userful's Infinity Platform's Role in Converging IT, OT, and Security for Mission-Critical Operations CALGARY, Alberta, Dec. 01, 2025 (GLOBE NEWSWIRE) — Userful Corporation, the leader in enterprise operations and observability infrastructure, today announced it has been named a Platinum Winner in the Information Technology – SaaS category at the

MROpen EVO at RSNA 2025: New MRI Scanning Function for Symptom-Driven Upright Pelvic Imaging

A Media Snippet accompanying this announcement is available by clicking on this link. CHICAGO, Dec. 01, 2025 (GLOBE NEWSWIRE) — MROpen EVO: Unveiling Next-Generation Sitting Pelvic Imaging and an Innovative On-board Control Interface at RSNA 2025. ASG Superconductors is proud to present the latest evolution of the MROpen EVO at RSNA 2025. As the world's

New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial of Tinlarebant in Adolescents with Stargardt Disease

New Hope for People Living with a Disease Once Deemed Untreatable: Belite Bio Announces Positive Topline Results from the Pivotal Global, Phase 3 DRAGON Trial of Tinlarebant in Adolescents with Stargardt Disease GlobeNewswire December 01, 2025 Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in a global Phase 3 trial for Stargardt disease,

Scroll to Top